Innate Pharma SA

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

25 documents for Innate Pharma SA

- Research and Markets: Kidney Cancer - Pipeline Review, H1 2012.
...* Astellas Pharma Inc., H1 2012. * Eisai Co., Ltd., H1 2012. * Ono P...* Innate Pharma SA, H1 2012. * Protox Therapeutics Inc., H1...
- Business Wire
- March 06, 2012
- Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
...(28) Innate immune system components also may contribute to co... is an investigator for Graceway Pharmaceuticals. . Dr. Green is an advisor, consultant, and invest...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 7, July 2011
- BIO Announces Therapeutic Workshops for 10th Annual BIO Investor Forum.
... the interest of investors as well as pharma companies that will pay top dollar to develop thes... Brailly, PhD, Chief Executive Officer, Innate Pharma SA; Kevin Heller, Director, Immuno-Oncology...
- Business Wire
- September 19, 2011

- Clinical Data Launches PGxPredict(TM):RITUXIMAB on Schedule.
Pharmacogenetic Test to Aid Physicians in Managing Therapy for Pat... to an intellectual property portfolio from Innate Pharma S.A. of Marseille, France. . PGxPredict:RIT...
- Business Wire
- January 30, 2007
- Innate Pharma Strengthens Its Platform in the Pharmacology of Toll-Like Receptors (TLR) with Assets Licensed from US-Based Global Pharmaceutical Company Schering-Plough Corporation.
MARSEILLE, France -- Innate Pharma Strengthens Its Platform in the Pharmacology of Toll-Like Receptors (TLR): --Assets Licensed from US-Based Global...
- Business Wire
- June 19, 2006
- VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development.
... Calle was head of business development at Innate Pharma, SA (Marseille, France - NYSE Euronext Pari...
- Business Wire
- December 04, 2007
- Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
...Pharmacologic treatments include both topical and oral medicatio... pathogenic mechanisms include augmented innate immune response, vascular hyperreactivity, increas...
- Journal of Drugs in Dermatology
- Vol. 9 Nbr. 6, June 2010
- BioPartnering Europe (BPE) Continues to Stand Out as Europe's Premier Biotech Partnering Conference.
... from the international biotech and pharma industry participated in BPE, which took place on ...(IVT), Indevus Pharmaceuticals, Inc., Innate Pharma, InNexus Biotechnology Inc., Intas Biopharm...
- Business Wire
- October 23, 2008
- IDM Pharma Reports First Quarter 2006 Financial Results.
... to destroy cancer cells by activating innate immunity, and the second to prevent tumor recurren...
- Business Wire
- May 15, 2006
- Innovative BioPartnering Europe Program Addresses Latest Trends Affecting the Biotech Industry Today.
... goals, and new this year, pharmaceutical companies and open house presenters will give feat..., Inc., InDex Pharmaceuticals AB, Innate Pharma, InNexus Biotechnology Inc., Intercept Phar...
- Business Wire
- September 05, 2007